Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Medical Economics|December 11, 2012
Essential medicine policy in China: pros and consShanlian Hu
Intractable & Rare Diseases Research|February 26, 2026
Progress in the research and pharmacoeconomic evaluation of drugs and devices for rare diseases in ChinaShanlian Hu
Advances in Therapy|January 11, 2023
Cost-Utility Analysis of Darolutamide Combined with Androgen Deprivation Therapy for Patients with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer in ChinaJian Ming, Yuxia Wu, Rong Han, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|July 16, 2015
Memantine for treatment of moderate or severe Alzheimer's disease patients in urban China: clinical and economic outcomes from a health economic modelShanlian Hu, Xin Yu, Shengdi Chen, et al.
Current Medical Research and Opinion|July 12, 2017
Need for hyperlipidemia management policy reform in China: learning from the global experienceWei Yu, Ruizhi Shi, Jim Li, et al.
Value in Health Regional Issues|October 28, 2017
Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging MarketsDiana Brixner, Nikos Maniadakis, Zoltán Kaló, et al.
Journal of Medical Economics|October 3, 2014
The cost-effectiveness of OM-85 in managing respiratory tract infections in ChinaJianwei Xuan, Lijie Wang, Hongjun Yin, et al.
Cost Effectiveness and Resource Allocation : C/E|January 16, 2020
Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic reviewHaiyin Wang, Chunlin Jin, Liang Fang, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 7, 2022
Cost-effectiveness of stereotactic body radiotherapy in the treatment of non-small-cell lung cancer (NSCLC): a systematic reviewHui Sun, Chunlin Jin, Huishan Wang, et al.
Journal of Medical Economics|April 11, 2022
Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucroseShanlian Hu, Limin Liu, Richard F Pollock, et al.
Pageof 4